These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1969984)

  • 1. Chronic hepatitis in kidney allograft recipients.
    Pol S; Debure A; Degott C; Carnot F; Legendre C; Brechot C; Kreis H
    Lancet; 1990 Apr; 335(8694):878-80. PubMed ID: 1969984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era.
    Yagisawa T; Toma H; Tanabe K; Ishikawa N; Tokumoto N; Iguchi Y; Goya N; Nakazawa H; Takahashi K; Ota K
    Am J Nephrol; 1997; 17(5):440-4. PubMed ID: 9382163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation.
    Pol S; Legendre C; Saltiel C; Carnot F; Bréchot C; Berthelot P; Mattlinger B; Kreis H
    J Hepatol; 1992 May; 15(1-2):202-6. PubMed ID: 1324270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients.
    Rao KV; Kasiske BL; Anderson WR
    Transplantation; 1991 Feb; 51(2):391-6. PubMed ID: 1994533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients.
    Parfrey PS; Forbes RD; Hutchinson TA; Beaudoin JG; Dauphinee WD; Hollomby DJ; Guttmann RD
    Transplantation; 1984 May; 37(5):461-6. PubMed ID: 6375001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.
    Yilmaz VT; Aliosmanoglu I; Erbis H; Ulger BV; Cetinkaya R; Suleymanlar G; Kocak H
    Transpl Infect Dis; 2016 Feb; 18(1):55-62. PubMed ID: 26565663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients.
    Samuel D; Bismuth A; Mathieu D; Arulnaden JL; Reynes M; Benhamou JP; Brechot C; Bismuth H
    Lancet; 1991 Apr; 337(8745):813-5. PubMed ID: 1672913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.
    Bang BK; Yang CW; Yoon SA; Kim YS; Chang YS; Yoon YS; Koh YB
    Nephron; 1995; 70(4):397-401. PubMed ID: 7477642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of hepatitis B and C in renal allograft recipients.
    Aroldi A; Lampertico P; Montagnino G; Passerini P; Villa M; Campise MR; Lunghi G; Tarantino A; Cesana BM; Messa P; Ponticelli C
    Transplantation; 2005 May; 79(9):1132-6. PubMed ID: 15880056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of viral hepatitis in solid organ transplantation].
    Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
    Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C in kidney recipients. Epidemiology and impact on kidney transplantation].
    Pol S; Legendre C; Saltiel C; Carnot F; Bréchot C; Berthelot P; Mattlinger B; Kreis H
    Presse Med; 1991 Nov; 20(40):2025-7. PubMed ID: 1837117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
    Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
    Zhang M; Wu R; Jiang J; Minuk GY; Niu J
    Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hepatitis B virus infection in alcoholic liver disease, HBsAg negative chronic active liver disease and primary liver cell cancer in Britain.
    Bassendine MF; Della Seta L; Salmeron J; Thomas HC; Sherlock S
    Liver; 1983 Apr; 3(2):65-70. PubMed ID: 6877051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplantation in patients with chronic hepatitis B virus infection: is the prognosis worse?
    Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Chang FY; Lee SD
    Dig Dis Sci; 2001 Mar; 46(3):469-75. PubMed ID: 11318517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of renal transplantation on the course of hepatitis B liver disease.
    Parfrey PS; Forbes RD; Hutchinson TA; Kenick S; Farge D; Dauphinee WD; Seely JF; Guttmann RD
    Transplantation; 1985 Jun; 39(6):610-5. PubMed ID: 3890290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Kidney Transplantation in Patients Exposed to Hepatitis B Virus: Analysis by Phase of Infection.
    Chopra B; Sureshkumar KK
    Transplant Proc; 2017 Mar; 49(2):278-280. PubMed ID: 28219584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.